Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“IMPLICATIONS In patients with residual hypertriglyceridemia despite statin treatment, a combination of ω- fatty acids an d ros uvastatin pr oduced a greater reduction of TGs and non-HDL-C than rosuvastatin alone.”
“Rosuvastatin … and rosuvastatin … omega-3 fatty acids were associated with increases of 64% (from 14.1 [1.0-48.0] to 18.4 [6.7-52.4] ng/…) and 61% (from 10.4 [6.6-38.4] to 14.0 [9.6-37.6] ng/mL, P = .04), respectively.”
Journal of cardiovascular pharmacology and therapeutics • 2012 | View Paper
“ Rosuvastatin plus omega-3 fatty acid therapy lead to a significant elevation in adiponectin serum levels from 4.1 ± 0.99 ng/mL to 7.99 ± 1.76 ng/mL compared to control P < 0.01.”